Unicycive Therapeutics (UNCY) Other Working Capital Changes (2020 - 2026)
Unicycive Therapeutics posted quarterly Other Working Capital Changes of $1.3 million for Q1 2026, up 1052.63% year-on-year from $109922.4 in Q1 2025, and up 956.08% on a QoQ basis from -$148000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) has 7 years of Other Working Capital Changes data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 1052.63% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $835000.0 (up 2.58% YoY), and the FY2025 full-year result was -$565000.0, down 42.32% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $1.3 million, up from -$148000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.4 million in Q3 2024 and bottomed at -$1.3 million in Q1 2024.
- The 5-year median for Other Working Capital Changes is -$133000.0 (2025), against an average of -$529.41.
- The widest annual swing landed in 2022, when Other Working Capital Changes tumbled 1106.67%; it then soared 2097.22% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $335000.0 in 2022, then slumped by 121.79% to -$73000.0 in 2023, then plunged by 72.6% to -$126000.0 in 2024, then fell by 17.46% to -$148000.0 in 2025, then soared by 956.08% to $1.3 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.3 million (Q1 2026), -$148000.0 (Q4 2025), and -$144000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | -148,000.00 |
| Dec 31, 2025 | -148,000.00 |
| Sep 30, 2025 | -144,000.00 |
| Sep 30, 2025 | -144,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Mar 31, 2025 | -133,000.00 |
| Mar 31, 2025 | -133,000.00 |
| Dec 31, 2024 | -126,000.00 |
| Dec 31, 2024 | -126,000.00 |
| Sep 30, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | -365,000.00 |
| Jun 30, 2024 | -365,000.00 |
| Mar 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | -1.34 Mn |
| Dec 31, 2023 | -73,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Jun 30, 2023 | 231,000.00 |
| Jun 30, 2023 | 231,000.00 |
| Mar 31, 2023 | -338,000.00 |
| Mar 31, 2023 | -338,000.00 |
| Dec 31, 2022 | 335,000.00 |
| Dec 31, 2022 | 335,000.00 |
| Sep 30, 2022 | 228,000.00 |
| Sep 30, 2022 | 228,000.00 |
| Jun 30, 2022 | -362,000.00 |
| Jun 30, 2022 | -362,000.00 |
| Mar 31, 2022 | -263,000.00 |
| Mar 31, 2022 | -263,000.00 |
| Dec 31, 2021 | -384,000.00 |
| Dec 31, 2021 | -384,000.00 |
| Sep 30, 2021 | 1.70 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | -30,000.00 |
| Jun 30, 2021 | -30,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Dec 31, 2020 | 385,000.00 |
| Dec 31, 2020 | 385,000.00 |
| Sep 30, 2020 | -12,000.00 |
| Sep 30, 2020 | -12,000.00 |